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Abstract
Background: The aim was to describe transfusion practice in critically ill patients at an international level and
evaluate the effects of red blood cell (RBC) transfusion on outcomes in these patients.
Methods: This was a pre-planned sub-study of the Intensive Care Over Nations audit, which involved 730 ICUs
in 84 countries and included all adult patients admitted between 8 May and 18 May 2012, except admissions
for routine postoperative surveillance.
Results: ICU and hospital outcomes were recorded. Among the 10,069 patients included in the audit, data related
to transfusion had been completed for 9553 (mean age 60 ± 18 years, 60% male); 2511 (26.3%) of these had received
a transfusion, with considerable variation among geographic regions. The mean lowest hemoglobin on the day of
transfusion was 8.3 ± 1.7 g/dL, but varied from 7.8 ± 1.4 g/dL in the Middle East to 8.9 ± 1.9 g/dL in Eastern Europe.
Hospital mortality rates were higher in transfused than in non-transfused patients (30.0% vs. 19.6%, p < 0.001) and
increased with increasing numbers of transfused units. In an extended Cox proportional hazard analysis, the relative
risk of in-hospital death was slightly lower after transfusion in the whole cohort (hazard ratio 0.98, confidence interval
0.96–1.00, p = 0.048). There was a stepwise decrease in the hazard ratio for mortality after transfusion with increasing
admission severity scores.
Conclusions: More than one fourth of critically ill patients are transfused during their ICU stay, with considerable
variations in transfusion practice among geographic regions. After adjustment for confounders, RBC transfusions were
associated with a slightly lower relative risk of in-hospital death, especially in the most severely ill patients, highlighting
the importance of taking the severity of illness into account when making transfusion decisions.
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Background
Red blood cell (RBC) transfusions are frequently admin-
istered in critically ill patients [1, 2], although probably
less so in recent years than in the past. RBC transfusion
may have beneficial effects by increasing oxygen delivery
to the tissues and improving the oxygen demand/supply
balance [3], but may also have some harmful effects. In
addition to possible type and cross-matching issues,
transfusions may be associated with transfusion-related
acute lung injury (TRALI), transfusion-associated
circulatory overload (TACO) and immunomodulating
effects resulting in a higher incidence of nosocomial
infections [4].
Prospective, randomized, controlled trials (RCTs) have
suggested that restrictive RBC transfusion strategies are
safe, but this may apply more to patients who are less se-
verely ill. Indeed, recent meta-analyses have suggested
caution in patients with cardiovascular disease [5], and
that restrictive strategies should be applied with particular
care in high-risk patients undergoing major surgery [6].
The uncertainty concerning the risk/benefit profile of
RBC transfusion in critically ill patients has fueled ongoing
debate on the subject over the last two decades. Moreover,
the heterogeneity of critical illness and the absence of
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universally accepted guidelines may influence RBC
transfusion practice in intensive care units (ICUs) world-
wide. Several regional observational studies [1, 7] have
reported on patterns of RBC transfusion in ICU patients,
but global differences in transfusion practice have not
been addressed. Such data would be useful from an
epidemiological point of view, and also to improve our
understanding of the factors that may influence transfu-
sion practice.
We used the worldwide Intensive Care Over Nations
(ICON) database, to investigate current transfusion
practices worldwide and the possible effect of transfu-
sion on outcomes.
Methods
This was a planned post-hoc analysis of the ICON data-
base. ICON was a multicenter, worldwide audit endorsed
by the World Federation of Societies of Intensive Care
and Critical Care Medicine (WFSICCM). Institutional
recruitment for participation was by open invitation and
was voluntary, with no financial incentive. Institutional
review board approval was obtained by the participating
institutions according to local ethical regulations.
Informed consent was not required due to the observa-
tional and anonymous nature of data collection in this
audit. The ICON audit collected data on 10,069 adult
(> 16 years of age) patients admitted to the participating
centers (Additional file 1) between 8 May and 18 May
2012. The 9553 patients for whom data related to
transfusion had been completed were included in the
present analysis.
Data collection and management
Details about the conduct of the audit, the data collected
and the definitions used are provided elsewhere [8]. Data
were collected prospectively using preprinted case report
forms (CRFs) and were electronically introduced by the
investigators using an Internet-based website. Data collec-
tion on admission included demographic data and data on
comorbid diseases (chronic obstructive pulmonary disease
(COPD), cancer, metastatic cancer, hematologic cancer,
insulin-dependent diabetes mellitus, heart failure (New
York Heart Association (NYHA) class III-IV), chronic
renal failure, human immunodeficiency virus (HIV)
infection, cirrhosis, immunosuppression, steroid therapy
or chemotherapy). Clinical data and laboratory data were
collected daily for a maximum of 28 days in the ICU, and
included respiratory, hemodynamic and hematological
parameters, and fluid administration. For the purposes of
this study, the minimum hemoglobin concentration
reported on the day of the transfusion was considered as
the “transfusion trigger”. ICU and hospital length of stay
and outcomes were recorded. Clinical and laboratory data
for the Simplified Acute Physiology Score (SAPS) II [9]
were reported as the worst value within 24 h after admis-
sion. A daily evaluation of organ function according to the
sequential organ failure assessment (SOFA) score [10] was
performed and organ failure was defined as a SOFA
score >2 for the organ in question. Surgical admissions
were identified as patients who had had surgery in the
4 weeks preceding admission.
Data were processed and analyzed in the Department
of Intensive Care of the University of Brussels. The study
coordinators processed all queries during data collection.
Detailed instructions, explaining the aim of the study,
instructions for data collection, and definitions for
various items were available through a secured website
for all participants. Validity checks were made concur-
rent with data entry by the electronic case record form,
including plausibility checks within each variable and
between variables. Data were further reviewed by the
coordinating center for plausibility and availability of the
outcome parameter, and doubts were clarified with the
corresponding ICU. We did not perform any other sup-
plementary quality control measures.
Subgroup analyses
Subgroups defined a priori included male versus female
patients, medical versus surgical patients, sepsis versus
no sepsis, and subgroups according to quartiles of SAPS
II and SOFA scores on admission to the ICU and age
categories (18–50, 51–65, 66–75 or > 75 years).
Statistical analysis
Data are summarized using means with standard
deviation (SD), medians and interquartile ranges (IQ) or
numbers and percentages. For the purposes of this
study, hemoglobin concentrations were categorized
according to cutoff values of < 7, 7–8.9, 9–10.9, 11–13,
and > 13 g/dL. Differences between groups were tested
using analysis of variance (ANOVA), the Kruskal-Wallis
test, Student’s t test, the Mann-Whitney test, the chi-
square test or Fisher’s exact test as appropriate.
To determine the adjusted relative risk of hospital death
after RBC transfusion during the ICU stay, we developed
an extended multivariable Cox model in the overall popu-
lation and in the subgroups defined a priori. We consid-
ered discharge as a competing event. Other confounding
variables considered for the Cox analysis included age,
sex, SAPS II score and SOFA sub-scores on admission to
the ICU, type of admission, the use of mechanical ventila-
tion or renal replacement therapy on ICU admission,
comorbidities, presence of sepsis and hemoglobin categor-
ies on admission to the ICU. We also adjusted for ICU
and hospital-related organizational factors including type
of hospital, hospital bed capacity, total number of ICU
patients in 2011, number of staffed ICU beds, number of
nurses and the presence of 24 h/day in-house intensivist
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coverage. The geographic region (North America, South
America, Western Europe, Eastern Europe, Middle East,
South Asia, East and South-East Asia, Oceania and Africa)
was considered in these multivariable models. An extended
Cox model was constructed, adding interaction terms that
involve time, i.e., time-varying fixed effects, computed as the
by-product of time and individual covariates in the model
(time × covariate). Individual time-varying fixed covariates
were introduced one by one and in combinations in the ex-
tended model, none of which was found to be significant
(Wald chi-square statistics). Colinearity between variables
was checked before modeling and all variables were in-
cluded in the models thereafter, irrespective of the level of
significance on univariate basis. Transfusion during the ICU
stay was introduced into the model as a time-dependent
variable using the time to the first erythrocyte unit given.
Data were analyzed using IBM® SPSS® Statistics soft-
ware, version 22 for windows. All reported p values are
two-sided. A p value of less than 0.05 was considered to
indicate statistical significance.
Results
Characteristics of the study group
The characteristics of the 9553 patients (mean age 60 ±
18 years, 60% male) on ICU admission are shown in
Table 1; 56% were medical admissions. Median ICU and
hospital lengths of stay were 3 (2-6) and 10 (5-20) days,
respectively, and the overall ICU and hospital mortality
rates were 16.2% and 22.3%, respectively. Patient charac-
teristics and outcomes varied among geographic regions
(Additional file 2: Table S1).
Global patterns of anemia and its relationship with
outcome
The mean lowest hemoglobin concentration on the day of
ICU admission was 10.7 ± 2.4 g/dL; 26.4% of patients had a
hemoglobin concentration < 9 g/dL on admission and 44.1%
of patients had a hemoglobin concentration < 9 g/dL dur-
ing the ICU stay. Hemoglobin concentrations were lower
during the first 2 weeks following ICU admission in pa-
tients who received a transfusion than in those who did
not (Additional file 2: Figure S1). In patients who did not
receive a transfusion at any time during the ICU stay,
hemoglobin concentrations decreased steadily after admis-
sion to the ICU (Additional file 2: Figure S1).
Hemoglobin concentrations varied considerably in the
different geographic regions (Fig. 1). On the day of ICU
admission, mean hemoglobin concentrations varied from
10.1 ± 2.3 g/dL in the Middle East to 11.3 ± 2.5 g/dL in
South Asia. The proportion of patients with severe anemia
(hemoglobin concentration < 7 g/dL) on admission to the
ICU ranged from 3.5% (Western Europe) to 12.0%
(Africa). The overall prevalence of anemia (hemoglobin
concentration < 9 g/dL) at any time during the ICU stay
ranged from 31.5% (South Asia) to 56.6% (Middle East).
There was an inverse relationship between the lowest
hemoglobin concentration on the day of ICU admission
and during the ICU stay and ICU and hospital mortality
rates and the degree of organ dysfunction/failure as assessed
by the SOFA score during the ICU stay (Additional file 2:
Table S2, Figure S2). Patients with a lowest hemoglobin
concentration of < 7 g/dL had an almost twofold higher
mortality rate than those with a lowest hemoglobin
concentration of > 13 g/dL on the day of ICU admission
(Additional file 2: Figure S2) or at any time during the ICU
stay. However, differences in mortality rates for hemoglobin
concentrations between 7 and 13 g/dL were less marked.
Transfusion practice
A total of 2511 (26.3%) patients received a RBC transfu-
sion during the ICU stay; 1192 (12.5%) patients received
a transfusion on the day of ICU admission. The propor-
tion of patients who received a transfusion varied con-
siderably among the different geographic regions, from
7.1% in South Asia to 19.4% in Eastern Europe on the
day of ICU admission, and from 15% in South Asia to
34.9% in Eastern Europe during the ICU stay (Fig. 2;
Additional file 2: Table S1).
There were 62% of patients with hemoglobin
levels < 7 g/dL who received a RBC transfusion dur-
ing the ICU stay, whereas only 3.7% of patients with
hemoglobin concentrations >13 g/dL received a transfusion
(Additional file 2: Table S3). The proportion of patients
who received a transfusion during the ICU stay increased
with increasing ICU length of stay (Additional file 1:
Table S4). Patients who received a transfusion at any time
during the ICU stay had higher SAPS II and SOFA scores
on admission to the ICU than those who did not (Table 1).
The median number of units transfused was 3 (IQ 2–5).
The mean lowest hemoglobin concentration on the day
of transfusion (transfusion trigger) for patients transfused
on the day of admission to the ICU was 8.3 ± 2.2 g/dL, but
varied according to age, type of admission, the presence of
sepsis, severity scores, ICU length of stay and geographic
region (Table 2). The transfusion trigger was higher in sur-
gical patients than in medical patients for transfusions on
the day of admission and at any time during the ICU stay.
Hemoglobin concentrations on the day of transfusion were
lower in patients with higher scores for severity of illness
than in patients with lower scores (Additional file 2:
Figure S3). The lowest transfusion trigger on the day of
transfusion was reported in the Middle East (7.7 ± 2.3 g/dL
on the day of admission to the ICU and 7.8 ± 1.4 g/dL at any
time during the ICU stay) and was the highest in Africa on
the day of admission (9.0 ± 2.4 g/dL) and in Eastern Europe
at any time during the ICU stay (8.9 ± 1.9) (Table 2, Figure 2).
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Table 1 Clinical characteristics and outcomes of the study cohort according to whether or not they received a transfusion during
their ICU stay
Characteristic All patients
N = 9553
No transfusion
N = 7042
Transfusion
N = 2511
p value
Age (years), mean ± SD 59.9 ± 18.0 59.5 ± 18.3 60.9 ± 17.3 0.002
Male, n (%) 5669 (60.1) 4180 (60.2) 1489 (59.8) 0.736
Admission severity scores, mean ± SD
SAPS II 41.3 ± 17.7 39.7 ± 17.7 45.7 ± 17.1 <0.001
SOFA score 6.4 ± 4.2 5.4 ± 3.7 8.1 ± 4.3 <0.001
Type of admission, n (%) <0.001
Medical 5089 (56.1) 4097 (61.2) 992 (40.9)
Surgical 3317 (36.6) 2063 (31.0) 1254 (51.7)
Trauma 607 (6.7) 436 (6.6) 171 (6.8)
Others 61 (0.7) 51 (0.8) 10 (0.4)
Source of admission, n (%) <0.001
Ambulance 3590 (37.6) 2974 (42.2) 616 (24.5)
Hospital floor 2512 (26.3) 1703 (24.2) 809 (32.2)
OR/ER 1749 (18.3) 1081 (15.4) 668 (26.6)
Other hospital 937 (9.8) 674 (9.6) 263 (10.5)
Others 765 (8.0) 610 (8.7) 155 (6.2)
Comorbid conditions
COPD 1182 (12.4) 907 (12.9) 275 (11.0) 0.012
Diabetes mellitus insulin-dependent 925 (9.7) 644 (9.1) 281 (11.2) 0.003
Chronic heart failure (NYHA III-IV) 875 (9.2) 627 (8.9) 248 (9.9) 0.147
Chronic renal failure 875 (9.2) 549 (7.8) 326 (13.0) <0.001
Non-metastatic cancer 1011 (10.6) 659 (9.4) 352 (14.0) <0.001
Immunosuppression 727 (7.6) 459 (6.5) 268 (10.7) <0.001
Cirrhosis 334 (3.5) 183 (2.6) 151 (6.0) <0.001
Metastatic cancer 320 (3.3) 201 (2.9) 119 (4.7) <0.001
Hematological cancer 207 (2.2) 110 (1.6) 97 (3.9) <0.001
HIV 69 (0.7) 46 (0.7) 23 (0.9) 0.182
Number of comorbidities, n (%) <0.001
Any 5195 (54.4) 3012 (42.8) 1346 (53.6)
1 2667 (27.9) 1936 (27.5) 731 (29.1)
2 1162 (12.2) 755 (10.7) 407 (16.2)
3 403 (4.2) 245 (3.5) 158 (6.3)
≥ 4 126 (1.3) 76 (1.1) 50 (2.0)
Mortality rates, n (%)
ICU 1507 (16.2) 976 (14.3) 531 (21.5) <0.001
Hospital 2006 (22.3) 1286 (19.6) 720 (30.0) <0.001
Length of stay, all patients, median (IQR)
ICU 3.0 (2.0–6.0) 3.0 (1.0–5.0) 5.0 (3.0–11.0) <0.001
Hospital 10.0 (5.0–20.0) 8.0 (4.0–16.0) 15.0 (7.0–30.0) <0.001
Length of stay, survivors, median (IQR)
ICU 3.0 (2.0–6.0) 2.0 (1.0–6.0) 5.0 (3.0–11.0) <0.001
Hospital 11.0 (6.0–21.0) 10.0 (5.0–18.0) 17.0 (9.0–35.0) <0.001
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Outcomes according to RBC transfusion status
ICU and hospital mortality rates were higher in patients
who received a transfusion during the ICU stay than in
those who did not (21.5% vs. 14.3% and 30.0% vs. 19.6%,
both p < 0.001) (Table 1). Mortality rates increased
with increasing numbers of transfused RBC units
(Additional file 2: Table S5). In the multivariable Cox analysis
in the whole cohort, the relative risk of in-hospital death was
slightly lower after transfusion (hazard ratio 0.98, confidence
interval 0.96–1.00, p = 0.048) (Additional file 2: Table S6).
Table 1 Clinical characteristics and outcomes of the study cohort according to whether or not they received a transfusion during
their ICU stay (Continued)
Characteristic All patients
N = 9553
No transfusion
N = 7042
Transfusion
N = 2511
p value
Length of stay, non-survivors, median (IQR)
ICU 3.0 (1.0–8.0) 2.0 (1.0–6.0) 7.0 (2.5–15.0) <0.001
Hospital 5.0 (2.0–13.0) 4.0 (1.0–9.0) 9.5 (3.0–20.5) <0.001
Missing values: age, sex, and type of admission in 50, 114 and 479 patients, respectively; percentages were calculated taking into account missing values
COPD chronic obstructive pulmonary disease, HIV human immunodeficiency viral infection, ICU intensive care unit, NYHA New York Heart Association
Classification, SAPS simplified acute physiology score, SOFA sequential organ assessment, SD standard deviation, ER emergency room, OR operating room
Fig. 1 Distribution of hemoglobin concentrations in the different geographic regions on admission (upper panel) and during the ICU stay (lower panel)
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Subgroup analysis
The adjusted hazard ratios of in-hospital mortality among
the pre-defined sub-groups are shown in Fig. 3. Transfu-
sion was associated with a lower hazard of death in med-
ical patients, in patients with a hemoglobin level < 7 g/dL,
and in patients with higher SAPS II (52–119) and SOFA
scores (>8) on ICU admission. There was a stepwise de-
crease in hazard ratio for mortality with transfusion ac-
cording to increasing admission severity scores (Fig. 3).
Discussion
The present study provides interesting information about
the epidemiology and impact of RBC transfusions in ICUs
around the globe. Despite the fact that the degree of
anemia in our study was comparable to that reported in
previous observational studies [1], the proportion of pa-
tients who received a RBC transfusion (26%) is lower than
that reported in older studies: for example, 37% in the
European ABC study [1] and 44% in the North American
CRIT study [7], which were comparable studies conducted
about 15 years ago, and 33% in the European SOAP study
conducted a few years later [2]. The transfusion triggers in
our study were slightly lower in patients admitted to ICUs
from Western Europe (8.1 g/dL) and North America
(7.9 g/dL) than those reported in the older ABC (8.4 g/dL)
and CRIT (8.6 g/dL) studies.
We observed considerable variation in transfusion
practice among geographic regions, and marked differ-
ences in pre-transfusion hemoglobin concentrations
according to age, type of admission, the presence of
sepsis, severity scores and ICU length of stay. There are
surprisingly few data on ICU transfusion practice in
areas of the world other than Europe, Oceania and
North America.
As expected, transfusions were associated with higher
severity scores, longer lengths of stay and higher mortal-
ity rates. The important finding was that in multivariable
analysis, RBC transfusion was associated with greater
benefit in sicker patients and with worse outcomes in
patients with lower severity scores. In the study by
Hebert et al. [11], mortality rates were also higher in the
liberal-strategy group than in the restrictive-strategy
group in patients with lower Acute Physiology and
Chronic Health Evaluation (APACHE) II scores.
A particular strength of this study is the large size of
the database, with participants from all geographical
regions; nevertheless, we acknowledge that contributions
from some areas were limited and may not be represen-
tative of the area in general. We also recognize other
limitations. First, contribution to the study was voluntary
and inclusion may have been subject to selection bias,
particularly in the less-represented regions. Moreover,
we did not adjust for repeated measures within ICUs or
regions, so that small numbers of clinicians within a few
large ICUs contributing a large amount of data may have
influenced the estimates, especially in smaller regions.
Second, although this was a predefined sub-study, the
original ICON study was not specifically designed to
investigate this topic and some potentially relevant
aspects were not available. For example, the indication
for red blood cell transfusion, especially acute bleeding,
was not recorded in our database, so that a possible
confounding effect cannot be excluded. In addition,
availability of blood for transfusion at the regional level
and differences in local transfusion guidelines may
influence decision making in this context. Nonetheless,
we did adjust for several factors related to the severity of
illness and the underlying disease process. As an
Fig. 2 Proportion of patients who received a red blood cell (RBC) transfusion during the ICU stay in the different geographic regions. Hb, hemoglobin
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Table 2 Characteristics of patients according to the lowest hemoglobin concentration on the day of transfusion
Lowest hemoglobin concentration on day of transfusion, mean ± SD
Characteristic Transfusion on day of admission Transfusion at any time during ICU staya
Number Numberb Min Max Mean
All patients 1170 8.3 ± 2.2 2470 7.9 ± 1.7 8.6 ± 1.8 8.3 ± 1.7
Age, years *** * ***
16–50 312 8.2 ± 2.4 605 7.7 ± 1.9 8.5 ± 1.9 8.1 ± 1.8
51–65 321 8.4 ± 2.1 731 7.9 ± 1.6 8.6 ± 1.7 8.2 ± 1.6
66–75 267 8.5 ± 2.1 578 8.0 ± 1.8 8.7 ± 1.7 8.4 ± 1.6
>75 267 8.3 ± 2.0 551 8.1 ± 1.7 8.7 ± 1.7 8.4 ± 1.7
Sex
Female 463 8.3 ± 2.1 984 7.9 ± 1.7 8.6 ± 1.8 8.2 ± 1.6
Male 693 8.3 ± 2.2 1466 7.9 ± 1.7 8.6 ± 1.8 8.3 ± 1.6
Type of admission *** *** *** ***
Surgical 671 8.8 ± 2.1 1237 8.2 ± 1.7 8.9 ± 1.8 8.6 ± 1.7
Medical 392 7.6 ± 2.1 973 7.5 ± 1.7 8.3 ± 1.7 7.9 ± 1.6
Trauma 69 8.4 ± 2.1 167 8.0 ± 1.6 8.7 ± 1.7 8.3 ± 1.6
Others 3 6.8 ± 2.6 10 7.9 ± 2.2 8.5 ± 2.2 8.2 ± 2.2
SAPS II *** *** *** ***
0–28 188 8.7 ± 2.4 345 8.2 ± 2.0 8.9 ± 2.0 8.6 ± 1.9
29–39 319 8.7 ± 2.2 657 8.2 ± 1.8 8.8 ± 1.8 8.5 ± 1.7
40–51 284 8.1 ± 2.0 655 7.7 ± 1.5 8.4 ± 1.6 8.1 ± 1.4
52–119 379 8.0 ± 2.0 813 7.7 ± 1.7 8.5 ± 1.8 8.1 ± 1.6
SOFA score on admission to the ICU * *** **
0–3 188 8.5 ± 2.5 353 8.2 ± 2.1 8.8 ± 1.9 8.5 ± 1.9
4–5 169 8.5 ± 2.3 375 8.1 ± 1.8 8.7 ± 1.8 8.4 ± 1.8
6–8 292 8.5 ± 2.0 665 8.0 ± 1.6 8.6 ± 1.7 8.3 ± 1.5
>8 521 8.1 ± 2.1 1077 7.7 ± 1.7 8.6 ± 1.8 8.1 ± 1.6
ICU length of stay, days *** *** *** ***
1 197 7.8 ± 2.3 235 7.8 ± 2.2 8.0 ± 2.2 7.9 ± 2.2
2–3 360 8.4 ± 2.1 589 8.2 ± 1.8 8.6 ± 1.8 8.4 ± 1.7
4–7 318 8.5 ± 2.1 629 8.1 ± 1.7 8.7 ± 1.8 8.4 ± 1.7
>7 271 8.3 ± 2.1 944 7.6 ± 1.5 8.7 ± 1.7 8.1 ± 1.4
Sepsis * **
No 734 8.4 ± 2.2 1283 8.1 ± 1.9 8.6 ± 1.8 8.4 ± 1.8
Yes 436 8.1 ± 2.0 1187 7.7 ± 1.6 8.6 ± 1.7 8.1 ± 1.5
Geographic region *** *** ** ***
Africa 24 9.0 ± 2.4 38 8.5 ± 2.2 9.1 ± 2 8.8 ± 2
Middle East 35 7.7 ± 2.3 111 7.4 ± 1.4 8.3 ± 1.6 7.8 ± 1.4
South America 86 8.7 ± 2.4 205 8.0 ± 2.0 8.7 ± 2.0 8.3 ± 1.9
North America 92 8.2 ± 2 183 7.5 ± 1.6 8.3 ± 1.6 7.9 ± 1.4
Western Europe 510 8.1 ± 1.8 1099 7.8 ± 1.4 8.5 ± 1.5 8.1 ± 1.4
Eastern Europe 211 8.8 ± 2.2 378 8.4 ± 2 9.3 ± 2 8.9 ± 1.9
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observational study, we cannot control for unmeasured
confounding as can RCTs, and can therefore only
demonstrate an association and not prove causality; our
findings can therefore only be considered as hypothesis-
generating. Nevertheless, unlike RCTs in which only a
fraction of potentially eligible patients are included,
observational studies include all patients thus providing
data that are more pragmatic and generalizable to the
whole ICU population. Third, although transfusion was
associated with a lower hazard of mortality in sicker pa-
tients, we are unable to comment on optimum thresh-
olds or targets of transfusion. Fourth, we lack information
on complications associated with transfusions, such as
TRALI, TACO, transfusion reactions and development of
nosocomial infections. We also have no information on
whether or not transfused units were leukocyte-depleted.
Conclusions
Despite the limitations mentioned, this large worldwide
study of patients admitted to the ICU shows clear differ-
ences in transfusion practice in different geographic re-
gions. Our results also suggest that RBC transfusion may
be associated with better outcomes in the most severely
ill patients, highlighting the importance of taking sever-
ity of illness into account when deciding on the need for
transfusion in an individual patient.
Fig. 3 Forest plot was created from modelling of our observational data showing the risk of in-hospital death after transfusion in the various
subgroups of patients. SAPS, Simplified Acute Physiology Score; SOFA, Sequential Organ Failure Assessment (on admission)
Table 2 Characteristics of patients according to the lowest hemoglobin concentration on the day of transfusion (Continued)
Lowest hemoglobin concentration on day of transfusion, mean ± SD
Characteristic Transfusion on day of admission Transfusion at any time during ICU staya
Number Numberb Min Max Mean
Oceania 39 8.5 ± 1.9 91 7.9 ± 1.5 8.5 ± 1.5 8.2 ± 1.4
South East Asia 110 8.0 ± 2.4 232 7.7 ± 1.9 8.5 ± 1.9 8.1 ± 1.8
South Asia 63 8.8 ± 3.2 133 8.1 ± 2.5 8.9 ± 2.4 8.5 ± 2.3
Hb hemoglobin, SOFA Sequential Organ Failure Assessment, SAPS II Simplified Acute Physiology Score II, ICU intensive care unit, IQ interquartile
aSome patients were transfused several times hence, minimum (Min), maximum (Max) and mean values are given
bIn total 2511 patients received a transfusion but numbers in different categories vary because of missing data
*p = 0.01–0.05; **p = 0.01–0.001; ***p < 0.001 among groups
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